October 2008
Indian Journal of Medical Microbiology;Oct2008, Vol. 26 Issue 4, p372
Academic Journal
No abstract available.


Related Articles

  • Nevirapine Resistance by Timing of HIV Type 1 Infection in Infants Treated with Single-Dose Nevirapine. Micek, Mark A.; Blanco, Ana Judith; Beck, Ingrid A.; Dross, Sandra; Matunha, Laurinda; Montoya, Pablo; Seidel, Kristy; Gantt, Soren; Matediane, Eduardo; Jamisse, Lilia; Gloyd, Stephen; Frenkel, Lisa M. // Clinical Infectious Diseases;5/15/2010, Vol. 50 Issue 10, p1405 

    Background. In women, single-dose nevirapine for prophylaxis against mother-to-child transmission of human immunodeficiency virus type 1 (HIV-1) selects for nevirapine-resistant HIV-1, which subsequently decays rapidly. We hypothesized that the selection, acquisition, and decay of...

  • Induction Therapy with Protease-Inhibitors Modifies the Effect of Nevirapine Resistance on Virologic Response to Nevirapine-based HAART in Children. Moorthy, Anitha; Kuhn, Louise; Coovadia, Ashraf; Meyers, Tammy; Strehlau, Renate; Sherman, Gayle; Wei-Yann Tsai; Ya Hui Chen; Abrams, Elaine J.; Persaud, Deborah // Clinical Infectious Diseases;2/15/2011, Vol. 52 Issue 4, p514 

    Background. Nevirapine resistance after failed prophylaxis to prevent mother-to-child human immunodeficiency virus (HIV) transmission can compromise subsequent nevirapine-based highly active antiretroviral therapy (HAART). Methods. Nevirapine-exposed children who achieved virologic suppression...

  • Nevirapine: A Review of its Use in the Prevention and Treatment of Paediatric HIV Infection. Bardsley-Elliot, A.; Perry, C.M. // Pediatric Drugs;Sep/Oct2000, Vol. 2 Issue 5, p373 

    Nevirapine is a highly specific inhibitor of HIV-1 reverse transcriptase (RT), an important therapeutic target for the treatment of HIV infection. It was the first non-nucleoside RT inhibitor (NNRTI) to be approved for use in HIV-infected individuals, including children. Nevirapine inhibits...

  • Resistance mutations may be decreasing among children with HIV.  // Infectious Diseases in Children;Oct2011, Vol. 24 Issue 10, p15 

    The article focuses on a study which examined the incidence rate of resistance mutations by antiretroviral class in children with human immunodeficiency virus (HIV).

  • NMR characterization of HIV-1 reverse transcriptase binding to various non-nucleoside reverse transcriptase inhibitors with different activities. Thammaporn, Ratsupa; Yagi-Utsumi, Maho; Yamaguchi, Takumi; Boonsri, Pornthip; Saparpakorn, Patchreenart; Choowongkomon, Kiattawee; Techasakul, Supanna; Kato, Koichi; Hannongbua, Supa // Scientific Reports;10/30/2015, p15806 

    Human immunodeficiency virus type 1 reverse transcriptase (HIV-1 RT) is an important target for antiviral therapy against acquired immunodeficiency syndrome. However, the efficiency of available drugs is impaired most typically by drug-resistance mutations in this enzyme. In this study, we...

  • Overview of HIV/AIDS in India. Marfatia, Y. S.; Sharma, Archana; Modi, Megha // Indian Journal of Sexually Transmitted Diseases;2007, Vol. 28 Issue 1, p1 

    Globally there are 40 million people living with human immunodeficiency virus (HIV)/ acquired immunodefi ciency syndrome (AIDS). According to latest estimates based on National Family Health Survey (NFHS), released by National AIDS Control Organization (NACO), the National adult HIV prevalence...

  • Nevirapine.  // AHFS Consumer Medication Information;Jan2020, p1 

    Nevirapine is used in combination with other medications to treat human immunodeficiency virus (HIV) infection in patients with or without acquired immunodeficiency syndrome (AIDS). Nevirapine is in a class of medications called non-nucleoside reverse transcriptase inhibitors (NNRTIs). It works...

  • Substitution of Nevirapine, Efavirenz, or Abacavir for Protease Inhibitors in Patients with Human Immunodeficiency Virus Infection. Martínez, Esteban; Arnaiz, Juan A.; Podzamczer, Daniel; Dalmau, David; Ribera, Esteban; Domingo, Pere; Knobel, Hernando; Riera, Melcior; Pedrol, Enric; Force, Lluis; Llibre, Josep M.; Segura, Ferran; Richart, Cristóbal; Cortés, Cristina; Javaloyas, Manuel; Aranda, Miquel; Cruceta, Ana; de Lazzari, Elisa; Gatell, José M. // New England Journal of Medicine;9/11/2003, Vol. 349 Issue 11, p1036 

    Background: We assessed the strategy of substituting nevirapine, efavirenz, or abacavir for a protease inhibitor in patients infected with human immunodeficiency virus type 1 (HIV-1) in whom virologic suppression had been achieved. Methods: We randomly assigned 460 adults who were taking two...

  • Methicillin-Resistant Staphylococcus aureus Infection in the Texas Prison System. Baillargeon, Jacques; Kelley, Michael F.; Leach, Charles T.; Baillargeon, Gwen; Pollock, Brad H. // Clinical Infectious Diseases;5/1/2004, Vol. 38 Issue 9, pe92 

    Recent reports indicate that correctional facility inmates may be at elevated risk for contracting methicillin-resistant Staphylococcus aureus (MRSA) infection because of overcrowding, poor hygiene, and high rates of diseases causing immunosuppression. The present study of 299,179 Texas inmates...

  • Once-daily dosing of nevirapine in HAART.  // Journal of Antimicrobial Chemotherapy (JAC);Jan2008, Vol. 61 Issue 1, p13 

    Non-nucleoside reverse transcriptase inhibitor (NNRTI)-based regimens provide simpler and more easily tolerated treatment alternatives to protease inhibitor-based regimens, potentially improving adherence. Long-term viral suppression relies on adherence to a prescribed antiretroviral treatment...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics